APA

Kang W. K., Park C., Yoon H. L., Kim W. S., Yoon S. S., Lee M. H., Park K., Kim K., Jeong H. S., Kim J. A., Nam S. J., Yang J. H., Son Y. I., Baek C. H., Han J., Ree H. J., Lee E. S., Kim S. H., Kim D. W., Ahn Y. C., Huh S. J., Choe Y. H., Lee J. H., Park M. H., Kong G. S., Park E. Y., Kang Y. K., Bang Y. J., Paik N. S., Lee S. N., Kim S. H., Kim S., Robbins P. D., Tahara H., Lotze M. T. & Park C. H. (20010830). Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. : Human gene therapy.

Chicago

Kang W K, Park C, Yoon H L, Kim W S, Yoon S S, Lee M H, Park K, Kim K, Jeong H S, Kim J A, Nam S J, Yang J H, Son Y I, Baek C H, Han J, Ree H J, Lee E S, Kim S H, Kim D W, Ahn Y C, Huh S J, Choe Y H, Lee J H, Park M H, Kong G S, Park E Y, Kang Y K, Bang Y J, Paik N S, Lee S N, Kim S H, Kim S, Robbins P D, Tahara H, Lotze M T and Park C H. 20010830. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. : Human gene therapy.

Harvard

Kang W. K., Park C., Yoon H. L., Kim W. S., Yoon S. S., Lee M. H., Park K., Kim K., Jeong H. S., Kim J. A., Nam S. J., Yang J. H., Son Y. I., Baek C. H., Han J., Ree H. J., Lee E. S., Kim S. H., Kim D. W., Ahn Y. C., Huh S. J., Choe Y. H., Lee J. H., Park M. H., Kong G. S., Park E. Y., Kang Y. K., Bang Y. J., Paik N. S., Lee S. N., Kim S. H., Kim S., Robbins P. D., Tahara H., Lotze M. T. and Park C. H. (20010830). Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. : Human gene therapy.

MLA

Kang W K, Park C, Yoon H L, Kim W S, Yoon S S, Lee M H, Park K, Kim K, Jeong H S, Kim J A, Nam S J, Yang J H, Son Y I, Baek C H, Han J, Ree H J, Lee E S, Kim S H, Kim D W, Ahn Y C, Huh S J, Choe Y H, Lee J H, Park M H, Kong G S, Park E Y, Kang Y K, Bang Y J, Paik N S, Lee S N, Kim S H, Kim S, Robbins P D, Tahara H, Lotze M T and Park C H. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. : Human gene therapy. 20010830.